Form 4 for ABT Abbott Laboratories
Accepted 2021-10-27 00:00:00 ET · period of report 2021-10-25 · accession 0001415889-21-004996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-27 | 2021-10-25 | ABT | Boudreau Philip P | VP | S - Sale | $126.49 | -8,000 | 16.9K | -32% | -$1.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-10-25 | S | D | 8,000 | $126.49 | 16,876 | D | — | — |